{"schema_version":"secwatch.filing_event.v1","accession":"0001551986-23-000024","form_type":"8-K","ticker":null,"cik":"0001551986","company_name":"9 METERS BIOPHARMA, INC.","filed_at":"2023-04-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.356548+00:00","generated_at":"2026-06-17T05:08:07.091739+00:00","sec_items":["1.01","3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"9 Meters Biopharma receives Nasdaq deficiency notice for low equity; faces note default","bullets":["March 31, 2023 Nasdaq letter for non-compliance with Rule 5550(b)(1) requiring $2.5M minimum stockholders' equity.","Reported stockholders' equity of $2,400,543 in Form 10-K for period ended December 31, 2023.","Non-compliance triggers default under $4,949,522 convertible note; holder can demand 115% of principal.","Company negotiating waiver; no immediate acceleration expected from the institutional investor.","Company has 45 days to submit compliance plan; if accepted, up to 180-day extension to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001551986-23-000024","json":"https://secwatch.observer/filing/0001551986-23-000024.json","markdown":"https://secwatch.observer/filing/0001551986-23-000024.md","text":"https://secwatch.observer/filing/0001551986-23-000024.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1551986/000155198623000024/0001551986-23-000024-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1551986/000155198623000024/nmtr-20230331.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T05:08:07.091739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cf52699309076ed4b19a5e5bc059cae2d128f0f3","claim":"9 METERS BIOPHARMA, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).","evidence_excerpt":"March 31, 2023, the Company received a letter from Nasdaq indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Stock Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In its annual report on Form 10-K for the period ended December 31, 2023, the Company reported stockholders’ equity of $2,400,543, and, as a result, does not currently satisfy Listing Rule 5550(b)(1). Nasdaq’s letter has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1551986/000155198623000024/0001551986-23-000024-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"stockholders equity"},{"label":"Rules","value":"5550(b)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}